Skip to main content
SpringerLink
Log in

Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Serum selenium levels were determined cross-sectionally in 57 HIV-infected patients who were classified according to the Centers for Disease Control (CDC) 1993 classification system. Mean serum selenium levels were lower in CDC stage II (58.7±12.2 μg/L;p<0.01;n=18) and stage III (47.6±11.3 μg/L;p<0.01;n=19) HIV-infected patients, than in healthy subjects (80.6±9.6 μg/L;n=48) and stage I patients (73.6±16.5 μg/L;n=20). Serum selenium levels were positively correlated with CD4 count, CD4/8 ratio, hematocrit, and serum albumin (r=0.42;r=0.39;r=0.48; andr=0.45;p<0.01, respectively) and inversely with serum levels of thymidine kinase (r=−0.49;p<0.01;n=49) and β2-microglobulin (r=−0.46;p<0.001;n=49). In addition, serum selenium levels in 20 randomly selected AIDS-free individuals (CDC I:n=10; CDC II:n=10) were inversely correlated with serum concentrations of interleukin-8 (IL-8) and soluble tumor necrosis factor receptors (sTNFR) types I and II. There was no correlation with serum immuneglobulin A and total serum protein levels. The results show that the progressive deprivation of serum selenium in HIV-infection is associated with loss of CD4+-cells and with increased levels of markers of disease progression and inflammatory response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A. Favier, C. Sappey, P. Leclerc, P. Faure, and M. Micoud, Antioxidant status and lipid peroxidation in patients infected with HIV.Chem. Biol. Interact. 91, 165–180 (1994).

    Article  PubMed  CAS  Google Scholar 

  2. B. Halliwell and C. E. Cross, Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Sense or speculation?Arch. Intern. Med. 151, 29–31 (1991).

    Article  PubMed  CAS  Google Scholar 

  3. F. Müller, Reactive oxygen intermediates and human immunodefiency virus (HIV) infection.Free Rad. Biol. Med. 13, 651–657 (1992).

    Article  PubMed  Google Scholar 

  4. H. C. Greenspan, Role of reactive oxygen species, antioxidants and phytopharmaceuticals in human immunodeficiency virus activity.Med. Hypoth. 40, 85–92 (1993).

    Article  CAS  Google Scholar 

  5. J. P. Revillard, C. Vincent, A. E. Favier, M. J. Richard, M. Zittoun, and M. D. Kazatchkine, Lipid peroxidation in human immunodeficiency virus infection.J. Acquired Immune Deficiency Syndrome 5, 63–68 (1992).

    Google Scholar 

  6. G. W. Pace and C. D. Leaf, The role of oxidative stress in HIV disease.Free Rad. Biol. Med. 19, 523–528 (1995).

    Article  PubMed  CAS  Google Scholar 

  7. T. Matsuyama, N. Kobayashi, and N. Yamamoto, Cytokines and HIV-infection: is AIDS a tumor necrosis factor disease?AIDS 5, 1405–1417 (1991).

    Article  PubMed  CAS  Google Scholar 

  8. T. Matsumoto, T. Miike, R. P. Nelson, W. L. Trudeau, R. F. Lockey, and J. Yodoi, Elevated serum levels of IL-8 in patients with HIV infection.Clin. Exp. Immunol. 93, 149–151 (1993).

    Article  PubMed  CAS  Google Scholar 

  9. G. E. Griffin, K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel, Activation of HIV gene expression during monocyte differentiation by induction of NFκB.Nature 339, 70–73 (1989).

    Article  PubMed  CAS  Google Scholar 

  10. G. Nabel and D. Baltimore, An inducible transcription factor activates expression of human immunodeficiency virus in T-cells.Nature 326, 711–713 (1987).

    Article  PubMed  CAS  Google Scholar 

  11. R. Schreck, K. Albermann, P. Bäuerle, Nuclear factor κB: An oxidative stress-response transcription factor of eukaryotic cells.Free Rad. Res. Comm. 17, 221–237 (1992).

    Article  CAS  Google Scholar 

  12. F. J. T. Staal, M. Roederer, P. Raju, M. T. Anderson, S. W. Ela, L. A. Herzenberg, and L. A. Herzenberg, Antioxidants inhibit stimulation of HIV transcription.AIDS Res. Hum. Retrovirus 9, 299–306 (1993).

    Article  CAS  Google Scholar 

  13. L. Kiremdjian-Schumacher and G. Stotzky, Selenium and immune responses.Environ, Res,42, 277–303 (1986).

    Article  Google Scholar 

  14. J. R. Stabel and J. W. Spears, Nutrition and Immunology; Role of selenium in immune responsiveness and disease resistance, inHuman Nutrition—A Comprehensive Treatise, vol. 8, D. M. Klurfeld, ed., Plenum, New York pp. 333–356 (1993).

    Google Scholar 

  15. H. T. Petrie, L. W. Klassen, and H. D. Kay, Selenium and the immune response: 1. Modulation of alloreactive human lymphocyte functions in vitro.J. Leukocyte Biol. 45, 207–214 (1989).

    PubMed  CAS  Google Scholar 

  16. L. Kiremidijan-Schumacher, M. Roy, H. I. Wishe, M. W. Cohen, and G. Stotzky, Supplementation with selenium and humane immune cell functions. Effect on cytotoxic lymphocytes and natural killer cells.Biol. Trace. Elem. Res. 41, 115–27 (1994).

    Google Scholar 

  17. M. Roy, L. Kiremdjian-Schumacher, H. I. Wishe, M. W. Cohnen, and G. Stotzky, Supplementation with selenium and human immune cell functions. Effect on lymphocyte proliferation and interleukin 2 receptor expression.Biol. Trace Elem. Res. 41, 103–114 (1994).

    PubMed  CAS  Google Scholar 

  18. A. Perez, J. Neve, J. Duchatateau, V. Siderova, J. P. Famaey, and Y. A. Carpentier, Effects of selenium supplementation on immune parameters in gut failure patients on home parenteral nutrition.Nutrition 7, 215–221 (1991).

    Google Scholar 

  19. D. Niese, P. Oehr, H. Scholtes, S. Ewig, J. Kempis, and H. H. Brackmann, Stellenwert der Thymidinkinase, des Beta-2-Mikroglobulins und des Neopterins bei der Prognoseabschätzung HIV-infizierter Hämophiliepatienten, inHämophilen Symposium Hamburg, E. Scharrer and W. Schramm, eds. Springer, Berlin pp. 78–88 (1991).

    Google Scholar 

  20. S. Sabbatani, A. Fini, E. Raise, and F. M. Gritti, Serum thymidine kinase (TK) evaluation in HIV infection.Int. J. Biol. Markers 4, 40–44 (1989).

    PubMed  CAS  Google Scholar 

  21. J. L. Fahey, J. M. G. Taylor, R. Detels, B. Hofman, R. Melmed, P. Nishanian, and J. V. Giorgi, The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type I.N. Engl. J. Med. 322, 166–172 (1990).

    Article  PubMed  CAS  Google Scholar 

  22. M. H. Godfried, T. van der Poll, J. Jansen, J. A. Romijin, L. K. M. Eeftinck Schattenkerk, E. Endert, S. J. H. van Deventer, and H. P. Sauerwein, Soluble receptors for tumor necrosis factor: A putative marker of disease progression in HIV infection.AIDS 7, 33–36 (1993).

    Article  PubMed  CAS  Google Scholar 

  23. Centers for Disease Control: 1993 revised classification system for HIV-infection and expanded surveillance case definition among adolescents and adults.Morbidity Mortality Weekly Rep. 41, 1–19 (1992).

    Google Scholar 

  24. B. Welz, M. Melcher, and G. Schlemmer, Bestimmung von Selen im menschlichen Blutserum.Anal. Chem. 316, 271–276 (1983).

    Article  CAS  Google Scholar 

  25. B. M. Dworkin, W. S. Rosenthal, G. P. Wormser, L. Weiss, M. Nunez, C. Joline, and A. Herp, Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex.Biol. Trace Elem. Res. 15, 167–177 (1988).

    PubMed  CAS  Google Scholar 

  26. K. Beck, P. Scramel, A. Hedl, H. Jaeger, and W. Kaboth, Serum trace element levels in HIV-infected subjects.Biol. Trace Elem. Res. 259, 2850–2851 (1990).

    Google Scholar 

  27. B. M. Dworkin, Selenium deficiency in HIV infection and the Acquireded immunodeficiency syndrome (AIDS).Chem. Biol. Interact. 91, 181–186 (1994).

    Article  PubMed  CAS  Google Scholar 

  28. A. Cirelli, M. Ciardi, C. De Simone, F. Sorice, R. Giordano, L. Ciaralli, and S. Constantini, Serum selenium concentration and disease progress with HIV-infection.Clin Biochem. 24, 211–214 (1991).

    Article  PubMed  CAS  Google Scholar 

  29. L. Olmsted, G. N. Schrauzer, M. Flores-Arce, and J. Dowd, Selenium supplementation of symptomatic human immunodeficiency virus infected patients.Biol. Trace Elem. Res. 20, 59–65 (1989).

    PubMed  CAS  Google Scholar 

  30. J. F. Zazzo, J. Chalas, A. Lafont, F. Camus, and P. Chappuis, Is non-obstructive cardiomyopathy in AIDS selenium-deficiency-related?J. Parent. Enteral. Nut. 12, 537–538 (1988).

    CAS  Google Scholar 

  31. G. Force, F. Marguet, and M. Manicacci, Selenium levels and HIV disease: clinical and biological correlations in patients with advanced AIDS. First International Conference Nutrition and HIV Infection, Cannes, France, April 28, 29 (1995).

  32. J. Constans, C. Sergeant, and J. L. Pellegrin, et al., Plasma selenium, zinc and copper in HIV-positive patients. First International Conference Nutrition and HIV Infection, Cannes, France, April 28, 29 (1995).

  33. N. M. H. Graham, On specific nutrient abnormalities in asymptomatic HIV-infection.AIDS 6, 1552–1553 (1992).

    Article  PubMed  CAS  Google Scholar 

  34. J. Constans, J. L. Pellegrin, and C. Sergeant, et al., Serum selenium predicts outcome in HIV infection.J. Acquired Immune Deficiency Syndrome 10, 392 (1995).

    Article  CAS  Google Scholar 

  35. A. Kalinkovich, G. Livshits, H. Engelmann, et al., Soluble tumor necrosis factor receptors (sTNF-R) and HIV-infection: correlation to CD8+ lymphocytes.Clin. Exp. Immunol. 93, 350–355 (1993).

    Article  PubMed  CAS  Google Scholar 

  36. R. Zangerle, H. Gallati, M. Scarletti, G. Weiss, H. Denz, H. Wachter, and D. Fuchs, Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.J. Acquired Immune Deficiency Syndrome 7, 79–85 (1994).

    CAS  Google Scholar 

  37. M. H. Godfried, T. van der Poll, G. J. Weverling, J. W. Mulder, J. Jansen, S. J. H. van Deventer, and H. P. Sauerwein, Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection.J. Inf. Dis. 169, 739–745 (1994).

    CAS  Google Scholar 

  38. P. A. Sandstrom, P. W. Tebbey, S. van Cleave, and T. M. Buttke, Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency.J. Biol. Chem. 269, 798–801 (1994).

    PubMed  CAS  Google Scholar 

  39. M. J. Christensen and N. W. Pusey, Binding of nuclear proteins to transcription regulatory elements in selenium deficiency.Biochem. Biophys. Acta. 1225, 338–341 (1994).

    PubMed  CAS  Google Scholar 

  40. C. Sappey, S. Legrand-Poels, M. Best-Belpomme, A. Favier, B. Rentier, and J. Piette, Stimulation of glutathione peroxidase activity decreases HIV Type 1 activation after oxidative stress.AIDS Res. Hum. Retrovir. 10, 1451–1459 (1994).

    PubMed  CAS  Google Scholar 

  41. E. W. Taylor, C. S. Ramanathan, R. K. Jalluri, and R. G. Nadimpalli, A basis for new approaches to the chemotherapy of AIDS: Novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression.J. Med. Chem. 37, 2637–2651 (1994).

    Article  PubMed  CAS  Google Scholar 

  42. H. C. Greensapan and O. I. Aruoma, Oxidative stress and apoptosis in HIV infection: a role for plant derived metabolites with synergistic antioxidant activity.Immunol. Today 15, 209–213 (1994).

    Article  Google Scholar 

  43. M. L. Gougeon and L. Montagnier, Apoptosis in AIDS.Science 260, 1269–1270 (1993).

    Article  PubMed  CAS  Google Scholar 

  44. B. Abrahams, D. Duncan, I. Hertz-Picciotto, A prospective study of dietary intake and Acquireded immune deficiency syndrome in HIV-seropositive homosexual men.J. Acquired Immune Deficiency Syndrome 6, 949–958 (1993).

    Google Scholar 

  45. G. O. Coodley, H. D. Nelson, M. O. Loveless, and C. Folk, Carotene in HIV infection,J. Acquired Immune Deficiency Syndrome 6, 272–276 (1993).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Internal Medicine, University of Bonn, Sigmund Freud-Strasse 25, 53105, Bonn, Germany

    Markus P. Look, Jürgen K. Rockstroh, Karl A. Kreuzer, Ulrich Spengler & Tilman Sauerbruch

  2. Institute for Clinical Biochemistry, University of Bonn, Sigmund Freud-Strasse 25, 53105, Bonn, Germany

    Govind S. Rao

Authors
  1. Markus P. Look
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen K. Rockstroh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Govind S. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karl A. Kreuzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ulrich Spengler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tilman Sauerbruch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Look, M.P., Rockstroh, J.K., Rao, G.S. et al. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 56, 31–41 (1997). https://doi.org/10.1007/BF02778982

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02778982

Index entries

Search

Navigation